Researchers' Work from School of Medicine Focuses on Lung Cancer

2011 DEC 27 -- New research, "Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer," is the subject of a report. According to the authors of recent research from Tokyo, Japan, "The purposes of this study were to assess the relationship of serum levels of pro-gastrin-releasing protein (ProGRP) and neuron-specific enolase (NSE) at relapse with survival after relapse and the response to salvage therapy and to assess whether serum levels of ProGRP and NSE at relapse are useful markers for detecting relapse earlier than are symptoms or radiographic findings in patients with...

Want to see the full article?

• Purchase this article for only $3.00